Beeram, M <br/><br/>
Akt-induced endocrine therapy resistance is reversed by inhibition of mTOR signaling.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Aug 2007 
 - 1323-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdm170  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Hormonal--pharmacology<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Aromatase Inhibitors--pharmacology<br/>Blotting, Western<br/>Breast Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Drug Resistance, Neoplasm--physiology<br/>Estradiol--analogs & derivatives<br/>Everolimus<br/>Female<br/>Flow Cytometry<br/>Fulvestrant<br/>Humans<br/>Letrozole<br/>Nitriles--pharmacology<br/>Protein Kinases--drug effects<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Sirolimus--analogs & derivatives<br/>TOR Serine-Threonine Kinases<br/>Triazoles--pharmacology